Skip to main content

Phase I study of vandetanib, imatinib mesylate, and hydroxyurea for recurrent malignant glioma

Publication ,  Conference
Kirkpatrick, JP; Vredenburgh, JJ; Desjardins, A; Gururangan, S; Peters, KB; Boulton, ST; Friedman, AH; Friedman, HS; Reardon, DA
Published in: JOURNAL OF CLINICAL ONCOLOGY
May 20, 2009

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

May 20, 2009

Volume

27

Issue

15

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

45th Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kirkpatrick, J. P., Vredenburgh, J. J., Desjardins, A., Gururangan, S., Peters, K. B., Boulton, S. T., … Reardon, D. A. (2009). Phase I study of vandetanib, imatinib mesylate, and hydroxyurea for recurrent malignant glioma. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 27). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
Kirkpatrick, J. P., J. J. Vredenburgh, A. Desjardins, S. Gururangan, K. B. Peters, S. T. Boulton, A. H. Friedman, H. S. Friedman, and D. A. Reardon. “Phase I study of vandetanib, imatinib mesylate, and hydroxyurea for recurrent malignant glioma.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 27. AMER SOC CLINICAL ONCOLOGY, 2009.
Kirkpatrick JP, Vredenburgh JJ, Desjardins A, Gururangan S, Peters KB, Boulton ST, et al. Phase I study of vandetanib, imatinib mesylate, and hydroxyurea for recurrent malignant glioma. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2009.
Kirkpatrick, J. P., et al. “Phase I study of vandetanib, imatinib mesylate, and hydroxyurea for recurrent malignant glioma.” JOURNAL OF CLINICAL ONCOLOGY, vol. 27, no. 15, AMER SOC CLINICAL ONCOLOGY, 2009.
Kirkpatrick JP, Vredenburgh JJ, Desjardins A, Gururangan S, Peters KB, Boulton ST, Friedman AH, Friedman HS, Reardon DA. Phase I study of vandetanib, imatinib mesylate, and hydroxyurea for recurrent malignant glioma. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2009.

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

May 20, 2009

Volume

27

Issue

15

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

45th Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences